{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T11:30:54Z","timestamp":1780918254947,"version":"3.54.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,4,21]],"date-time":"2015-04-21T00:00:00Z","timestamp":1429574400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s00296-015-3269-2","type":"journal-article","created":{"date-parts":[[2015,4,20]],"date-time":"2015-04-20T06:29:47Z","timestamp":1429511387000},"page":"1625-1630","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Semaphorin 3A: an immunoregulator in systemic sclerosis"],"prefix":"10.1007","volume":"35","author":[{"given":"Doron","family":"Rimar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuval","family":"Nov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itzhak","family":"Rosner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gleb","family":"Slobodin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rozenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Halasz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tharwat","family":"Haj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nizar","family":"Jiries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Kaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Boulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahava","family":"Vadasz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,21]]},"reference":[{"key":"3269_CR1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0962-8924(96)81033-6","volume":"6","author":"AL Kolodkin","year":"1996","unstructured":"Kolodkin AL (1996) Semaphorins: mediators of repulsive growth cone guidance. Trends Cell Biol 6:15\u201322","journal-title":"Trends Cell Biol"},{"issue":"1","key":"3269_CR2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12016-013-8360-4","volume":"47","author":"Z Vadasz","year":"2014","unstructured":"Vadasz Z, Toubi E (2014) Semaphorins: their dual role in regulating immune-mediated diseases. Clin Rev Allergy Immunol 47(1):17\u201325","journal-title":"Clin Rev Allergy Immunol"},{"key":"3269_CR3","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.autrev.2010.07.014","volume":"9","author":"Z Vadasz","year":"2010","unstructured":"Vadasz Z, Attias D, Kessel A, Toubi E (2010) Neuropilins and semaphorins\u2014from angiogenesis to autoimmunity. Autoimmun Rev 9:825\u2013829","journal-title":"Autoimmun Rev"},{"key":"3269_CR4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ni1553","volume":"9","author":"K Suzuki","year":"2008","unstructured":"Suzuki K, Kumanogoh A, Kikutani H (2008) Semaphorins and their receptors in immune cell interactions. Nat Immunol 9:17\u201323","journal-title":"Nat Immunol"},{"key":"3269_CR5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.humimm.2009.01.026","volume":"70","author":"JD Ji","year":"2009","unstructured":"Ji JD, Park-Min KH, Ivashkiv LB (2009) Expression and function of semaphorin 3A and its receptors in human monocyte-derived macrophages. Hum Immunol 70:211\u2013217","journal-title":"Hum Immunol"},{"key":"3269_CR6","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1002\/eji.200535601","volume":"36","author":"Y Lepelleteir","year":"2006","unstructured":"Lepelleteir Y, Moura IC, Hadj-Slimane R, Renand A, Fiorentino S, Baude C et al (2006) Immunosuppressive role of semaphorin 3A on T cell proliferation is mediated by inhibition of actin cytoskeleton reorganization. Eur J Immunol 36:1782\u20131793","journal-title":"Eur J Immunol"},{"key":"3269_CR7","first-page":"14","volume":"23","author":"S Takagawa","year":"2013","unstructured":"Takagawa S, Nakamura F, Kumagai K, Nagashima Y, Goshima Y, Saito T (2013) Decreased semaphorin3A expression correlates with disease activity and histological features of rheumatoid arthritis. BMC Musculoskelet Disord 23:14\u201340","journal-title":"BMC Musculoskelet Disord"},{"key":"3269_CR8","doi-asserted-by":"crossref","first-page":"R146","DOI":"10.1186\/ar3881","volume":"14","author":"Z Vadasz","year":"2012","unstructured":"Vadasz Z, Haj T, Halasz K, Rosner I, Slobodin G, Attias D et al (2012) Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosus. Arthritis Res Ther 14:R146","journal-title":"Arthritis Res Ther"},{"key":"3269_CR9","doi-asserted-by":"crossref","unstructured":"Cordiali-Fei P, Mussi A, Bordignon V, Trincone S, Vento A, Sperduti I et al (2013) Assessment of T regulatory cells and expanded profiling of autoantibodies may offer novel biomarkers for the clinical management of systemic sclerosis and undifferentiated connective tissue disease. Clin Dev Immunol 2013:390563","DOI":"10.1155\/2013\/390563"},{"key":"3269_CR10","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/j.1365-2133.2010.09633.x","volume":"162","author":"E Antiga","year":"2010","unstructured":"Antiga E, Quaglino P, Bellandi S, Volpi W, Del Bianco E, Comessatti A et al (2010) Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea. Br J Dermatol 162:1056\u20131063","journal-title":"Br J Dermatol"},{"key":"3269_CR11","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1586\/eci.11.28","volume":"7","author":"MR Jocea","year":"2011","unstructured":"Jocea MR, van Amelsfort M, Walter GJ, Taams LS (2011) CD4+CD25+ regulatory T cells in systemic sclerosis and other rheumatic diseases. Expert Rev Clin Immunol 7:499\u2013514","journal-title":"Expert Rev Clin Immunol"},{"key":"3269_CR12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cellimm.2009.12.009","volume":"261","author":"G Slobodin","year":"2010","unstructured":"Slobodin G, Ahmad MS, Rosner I, Peri R, Rozenbaum M, Kessel A et al (2010) Regulatory T cells (CD4(+)CD25(bright)FoxP3(+)) expansion in systemic sclerosis correlates with disease activity and severity. Cell Immunol 261:77\u201380","journal-title":"Cell Immunol"},{"key":"3269_CR13","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/j.1582-4934.2010.01027.x","volume":"14","author":"M Manetti","year":"2010","unstructured":"Manetti M, Guiducci S, Ibba-Manneschi L, Matucci-Cerinic M (2010) Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis. J Cell Mol Med 14:1241\u20131254","journal-title":"J Cell Mol Med"},{"key":"3269_CR14","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/ar2187","volume":"9","author":"AE Koch","year":"2007","unstructured":"Koch AE, Distler O (2007) Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis. Arthritis Res Ther 9:S3","journal-title":"Arthritis Res Ther"},{"key":"3269_CR15","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1582-4934.2005.tb00379.x","volume":"9","author":"AM Byrne","year":"2005","unstructured":"Byrne AM, Bouchier-Hayes DJ, Harmey JH (2005) Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J Cell Mol Med 9:777\u2013794","journal-title":"J Cell Mol Med"},{"key":"3269_CR16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/01.RES.0000134644.89917.96","volume":"95","author":"O Distler","year":"2004","unstructured":"Distler O, Distler JH, Scheid A, Acker T, Hirth A, Rethage J et al (2004) Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis. Circ Res 95:109\u2013116","journal-title":"Circ Res"},{"key":"3269_CR17","first-page":"641","volume":"20","author":"Z Mackiewicz","year":"2002","unstructured":"Mackiewicz Z, Sukura A, Povilenait\u00e9 D, Ceponis A, Virtanen I, Hukkanen M et al (2002) Increased but imbalanced expression of VEGF and its receptors has no positive effect on angiogenesis in systemic sclerosis skin. Clin Exp Rheumatol 20:641\u2013646","journal-title":"Clin Exp Rheumatol"},{"key":"3269_CR18","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1186\/ar596","volume":"4","author":"O Distler","year":"2002","unstructured":"Distler O, Del Rosso A, Giacomelli R, Cipriani P, Conforti ML, Guiducci S et al (2002) Angiogenesis and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers. Arthritis Res 4:R11","journal-title":"Arthritis Res"},{"key":"3269_CR19","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3899\/jrheum.080516","volume":"36","author":"LK Hummers","year":"2009","unstructured":"Hummers LK, Hall A, Wigley FM, Simons M (2009) Abnormalities in the regulators of angiogenesis in patients with scleroderma. J Rheumatol 36:576\u2013582","journal-title":"J Rheumatol"},{"key":"3269_CR20","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.autrev.2006.12.006","volume":"6","author":"S Guiducci","year":"2007","unstructured":"Guiducci S, Giacomelli R, Matucci-Cerinic M (2007) Vascular complications of scleroderma. Autoimmun Rev 6:520\u2013523","journal-title":"Autoimmun Rev"},{"key":"3269_CR21","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/ard.2007.079756","volume":"67","author":"A Sulli","year":"2008","unstructured":"Sulli A, Secchi ME, Pizzorni C, Cutolo M (2008) Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients. Ann Rheum Dis 67:885\u2013887","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-015-3269-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-015-3269-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-015-3269-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T07:28:30Z","timestamp":1559028510000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-015-3269-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,21]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["3269"],"URL":"https:\/\/doi.org\/10.1007\/s00296-015-3269-2","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,21]]}}}